Track 17: PET-CT and Hybrid Imaging

Sub-tracks of PET-CT and Hybrid Imaging:
Molecular imaging, Nuclear medicine techniques, PET radiotracers, FDG-PET applications, PET-MRI technology, Image fusion methods, Radiopharmaceutical development, Oncology PET, Cardiac PET, Neurological PET, Quantitative imaging, Hybrid scanner advancements.

PET-CT and Hybrid Imaging:
PET-CT (Positron Emission Tomography–Computed Tomography) and other hybrid imaging systems combine functional and structural imaging into a single examination. PET shows metabolic and physiological activity, while CT provides detailed anatomical information. When combined, they offer more accurate detection, localization, and monitoring of various diseases.

An overview of PET-CT and Hybrid Imaging:
Hybrid imaging has greatly advanced medical diagnosis by allowing healthcare professionals to observe disease processes at both molecular and structural levels. In oncology, PET-CT is widely used to locate tumors, determine their spread, assess response to treatment, and detect recurrence. In neurology, it helps evaluate brain metabolism and diagnose conditions such as dementia or seizure disorders. In cardiology, PET-CT assists in assessing heart muscle viability and blood flow.

Emerging technologies like PET-MRI provide higher soft-tissue contrast and reduced radiation exposure, making them particularly useful in neurological and pediatric imaging. As hybrid imaging continues to evolve, it supports more accurate diagnosis, personalized treatment planning, and improved patient outcomes.